An increasing amount of data suggests that psychedelic substances could be beneficial in the treatment of a variety of mental health issues. However, establishing their clinical benefits and overcoming the various regulatory barriers to their usage remain significant hurdles. The September
The University of Tennessee Health Science Centre is conducting research to find a novel technique to treat ischemic stroke, which is the top cause of mortality in people globally.
Beta-blockers may slow the progression of OA by reducing inflammatory mediators involved in cartilage degeneration – which may provide clues to the development of new treatment approaches for OA.
It can be difficult to recognise that you have glaucoma. In a study conducted at the University of Gothenburg, over 5% of 70-year-olds were found to have glaucoma, and half of those identified were ignorant of their condition.
Leaders of the G20 summit will be treated with first-of-its-kind instrumental music performances showcasing the cultural depth of Bharat on the occasion to be hosted by the President of India on September 9.
The new device, the size and shape of a grain of rice, can run dozens of trials at once to evaluate the impact of novel medicines on some of the most difficult-to-treat brain malignancies.
Geneva [Switzerland], September 6: The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which i
According to the findings of a multicenter phase II clinical trial, treating patients with differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, in addition to their treatment with the targeted tyrosine kinase inhibitor (TKI) cedir